Cat.#: ACPP-1392
| Despition | Dopa Decarboxylase Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1628 | Human LIF Protein, GST (AC1628) | 2 µg | inquiry |
| ACPP-1597 | Human CRYGS Protein (AC1597) | 5 µg | inquiry |
| ACPP-1335 | Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide (AC1335) | 250 µg | inquiry |
| ACPP-1718 | Human ASRGL1 Protein (AC1718) | 2 µg | inquiry |
| ACPP-1318 | Orexin A Blocking Peptide (AC1318) | 250 µg | inquiry |
| ACPP-1275 | Usherin Blocking Peptide (AC1275) | 250 µg | inquiry |
| ACPP-1155 | Recombinant Human PCDH18 Protein (6×His Tag) (AC1155) | 50 µg | inquiry |
| ACPP-1087 | Recombinant Human IL-6 Protein (Fc Chimera 6xHis Tag) (AC1087) | 50 µg | inquiry |
| ACPP-1534 | Human RLN3 Protein (AC1534) | 5 µg | inquiry |
| ACPP-1024 | Recombinant Human FGF2 Protein (mutated Q65I + C96S + N111G). (AC1024) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.